A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

PALM SPRINGS, Calif. (KESQ) -The CDC says prostate cancer is the second leading cause of cancer death in American men, behind lung cancer. With prostate cancer cases on the rise across the nation ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. NTNU has now created an AI diagnostic tool that can help lighten the burden.

Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm. The post New state-of-the-art test identifies ...

An experimental immunotherapy drug called VIR-5500 has driven prostate-specific antigen (PSA) levels down by as much as 99% in some men with metastatic castration-resistant prostate cancer, according ...